SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ARRIS - Another partner

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: David Bogdanoff who wrote (347)1/9/1998 9:54:00 AM
From: Biomaven  Read Replies (1) of 353
 
David,

Well if the arbitrageurs unwind by buying Arris, they would also have to sell their SQNA. Either way, there is no net upward pressure on Arris stock by the short covering/unwinding.

Personally I think the decline stemmed from a combination of disenchantment with the merger by a few large holders and the arbitrage pressure, with no offsetting buying. (With maybe some tax-selling thrown in).

I'm happy with the fundamentals, and I think we'll see gains from here (if the overall biotech market holds up). I'm thinking of increasing my small holding.

Peter
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext